1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Circulating Tumor Cells (CTCs) 1.2.3 Cell-Free DNA (CfDNA) 1.2.4 Extracellular Vesicles (EVs) 1.2.5 Other Circulating Biomarkers 1.3 Market by Application 1.3.1 Global Breast Cancer Liquid Biopsy Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospitals 1.3.3 Diagnostic Centers 1.3.4 Laboratories 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Breast Cancer Liquid Biopsy Market Perspective (2016-2027) 2.2 Breast Cancer Liquid Biopsy Growth Trends by Regions 2.2.1 Breast Cancer Liquid Biopsy Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Breast Cancer Liquid Biopsy Historic Market Share by Regions (2016-2021) 2.2.3 Breast Cancer Liquid Biopsy Forecasted Market Size by Regions (2022-2027) 2.3 Breast Cancer Liquid Biopsy Industry Dynamic 2.3.1 Breast Cancer Liquid Biopsy Market Trends 2.3.2 Breast Cancer Liquid Biopsy Market Drivers 2.3.3 Breast Cancer Liquid Biopsy Market Challenges 2.3.4 Breast Cancer Liquid Biopsy Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue 3.1.1 Global Top Breast Cancer Liquid Biopsy Players by Revenue (2016-2021) 3.1.2 Global Breast Cancer Liquid Biopsy Revenue Market Share by Players (2016-2021) 3.2 Global Breast Cancer Liquid Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Breast Cancer Liquid Biopsy Revenue 3.4 Global Breast Cancer Liquid Biopsy Market Concentration Ratio 3.4.1 Global Breast Cancer Liquid Biopsy Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Liquid Biopsy Revenue in 2020 3.5 Breast Cancer Liquid Biopsy Key Players Head office and Area Served 3.6 Key Players Breast Cancer Liquid Biopsy Product Solution and Service 3.7 Date of Enter into Breast Cancer Liquid Biopsy Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Breast Cancer Liquid Biopsy Breakdown Data by Type 4.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Type (2016-2021) 4.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2022-2027) 5 Breast Cancer Liquid Biopsy Breakdown Data by Application 5.1 Global Breast Cancer Liquid Biopsy Historic Market Size by Application (2016-2021) 5.2 Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Breast Cancer Liquid Biopsy Market Size (2016-2027) 6.2 North America Breast Cancer Liquid Biopsy Market Size by Type 6.2.1 North America Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) 6.2.2 North America Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) 6.2.3 North America Breast Cancer Liquid Biopsy Market Size by Type (2016-2027) 6.3 North America Breast Cancer Liquid Biopsy Market Size by Application 6.3.1 North America Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) 6.3.2 North America Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) 6.3.3 North America Breast Cancer Liquid Biopsy Market Size by Application (2016-2027) 6.4 North America Breast Cancer Liquid Biopsy Market Size by Country 6.4.1 North America Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) 6.4.2 North America Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Breast Cancer Liquid Biopsy Market Size (2016-2027) 7.2 Europe Breast Cancer Liquid Biopsy Market Size by Type 7.2.1 Europe Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) 7.2.2 Europe Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) 7.2.3 Europe Breast Cancer Liquid Biopsy Market Size by Type (2016-2027) 7.3 Europe Breast Cancer Liquid Biopsy Market Size by Application 7.3.1 Europe Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) 7.3.2 Europe Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) 7.3.3 Europe Breast Cancer Liquid Biopsy Market Size by Application (2016-2027) 7.4 Europe Breast Cancer Liquid Biopsy Market Size by Country 7.4.1 Europe Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) 7.4.2 Europe Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size (2016-2027) 8.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type 8.2.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2016-2027) 8.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application 8.3.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2016-2027) 8.4 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region 8.4.1 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Breast Cancer Liquid Biopsy Market Size (2016-2027) 9.2 Latin America Breast Cancer Liquid Biopsy Market Size by Type 9.2.1 Latin America Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) 9.2.2 Latin America Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) 9.2.3 Latin America Breast Cancer Liquid Biopsy Market Size by Type (2016-2027) 9.3 Latin America Breast Cancer Liquid Biopsy Market Size by Application 9.3.1 Latin America Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) 9.3.2 Latin America Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) 9.3.3 Latin America Breast Cancer Liquid Biopsy Market Size by Application (2016-2027) 9.4 Latin America Breast Cancer Liquid Biopsy Market Size by Country 9.4.1 Latin America Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) 9.4.2 Latin America Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size (2016-2027) 10.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type 10.2.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2016-2027) 10.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application 10.3.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2016-2027) 10.4 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country 10.4.1 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 QIAGEN 11.1.1 QIAGEN Company Details 11.1.2 QIAGEN Business Overview 11.1.3 QIAGEN Breast Cancer Liquid Biopsy Introduction 11.1.4 QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.1.5 QIAGEN Recent Development 11.2 Roche Diagnostics 11.2.1 Roche Diagnostics Company Details 11.2.2 Roche Diagnostics Business Overview 11.2.3 Roche Diagnostics Breast Cancer Liquid Biopsy Introduction 11.2.4 Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.2.5 Roche Diagnostics Recent Development 11.3 Bio-Rad Laboratories 11.3.1 Bio-Rad Laboratories Company Details 11.3.2 Bio-Rad Laboratories Business Overview 11.3.3 Bio-Rad Laboratories Breast Cancer Liquid Biopsy Introduction 11.3.4 Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.3.5 Bio-Rad Laboratories Recent Development 11.4 Myriad Genetics 11.4.1 Myriad Genetics Company Details 11.4.2 Myriad Genetics Business Overview 11.4.3 Myriad Genetics Breast Cancer Liquid Biopsy Introduction 11.4.4 Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.4.5 Myriad Genetics Recent Development 11.5 Menarini Silicon Biosystems 11.5.1 Menarini Silicon Biosystems Company Details 11.5.2 Menarini Silicon Biosystems Business Overview 11.5.3 Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Introduction 11.5.4 Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.5.5 Menarini Silicon Biosystems Recent Development 11.6 Genomic Health 11.6.1 Genomic Health Company Details 11.6.2 Genomic Health Business Overview 11.6.3 Genomic Health Breast Cancer Liquid Biopsy Introduction 11.6.4 Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.6.5 Genomic Health Recent Development 11.7 Thermo Fisher Scientific 11.7.1 Thermo Fisher Scientific Company Details 11.7.2 Thermo Fisher Scientific Business Overview 11.7.3 Thermo Fisher Scientific Breast Cancer Liquid Biopsy Introduction 11.7.4 Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.7.5 Thermo Fisher Scientific Recent Development 11.8 Illumina 11.8.1 Illumina Company Details 11.8.2 Illumina Business Overview 11.8.3 Illumina Breast Cancer Liquid Biopsy Introduction 11.8.4 Illumina Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.8.5 Illumina Recent Development 11.9 Biocept 11.9.1 Biocept Company Details 11.9.2 Biocept Business Overview 11.9.3 Biocept Breast Cancer Liquid Biopsy Introduction 11.9.4 Biocept Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.9.5 Biocept Recent Development 11.10 Trovagene 11.10.1 Trovagene Company Details 11.10.2 Trovagene Business Overview 11.10.3 Trovagene Breast Cancer Liquid Biopsy Introduction 11.10.4 Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.10.5 Trovagene Recent Development 11.11 Guardant Health 11.11.1 Guardant Health Company Details 11.11.2 Guardant Health Business Overview 11.11.3 Guardant Health Breast Cancer Liquid Biopsy Introduction 11.11.4 Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.11.5 Guardant Health Recent Development 11.12 RainDance Technologies 11.12.1 RainDance Technologies Company Details 11.12.2 RainDance Technologies Business Overview 11.12.3 RainDance Technologies Breast Cancer Liquid Biopsy Introduction 11.12.4 RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.12.5 RainDance Technologies Recent Development 11.13 MDx Health 11.13.1 MDx Health Company Details 11.13.2 MDx Health Business Overview 11.13.3 MDx Health Breast Cancer Liquid Biopsy Introduction 11.13.4 MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) 11.13.5 MDx Health Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Breast Cancer Liquid Biopsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Circulating Tumor Cells (CTCs) Table 3. Key Players of Cell-Free DNA (CfDNA) Table 4. Key Players of Extracellular Vesicles (EVs) Table 5. Key Players of Other Circulating Biomarkers Table 6. Global Breast Cancer Liquid Biopsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Breast Cancer Liquid Biopsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Breast Cancer Liquid Biopsy Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Breast Cancer Liquid Biopsy Market Share by Regions (2016-2021) Table 10. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Breast Cancer Liquid Biopsy Market Share by Regions (2022-2027) Table 12. Breast Cancer Liquid Biopsy Market Trends Table 13. Breast Cancer Liquid Biopsy Market Drivers Table 14. Breast Cancer Liquid Biopsy Market Challenges Table 15. Breast Cancer Liquid Biopsy Market Restraints Table 16. Global Breast Cancer Liquid Biopsy Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Breast Cancer Liquid Biopsy Market Share by Players (2016-2021) Table 18. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Liquid Biopsy as of 2020) Table 19. Ranking of Global Top Breast Cancer Liquid Biopsy Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Breast Cancer Liquid Biopsy Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Breast Cancer Liquid Biopsy Product Solution and Service Table 23. Date of Enter into Breast Cancer Liquid Biopsy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million) Table 26. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2016-2021) Table 27. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Breast Cancer Liquid Biopsy Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2016-2021) Table 31. Global Breast Cancer Liquid Biopsy Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Breast Cancer Liquid Biopsy Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million) Table 34. North America Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million) Table 36. North America Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Breast Cancer Liquid Biopsy Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Breast Cancer Liquid Biopsy Market Size by Country (2022-2027) & (US$ Million) Table 63. QIAGEN Company Details Table 64. QIAGEN Business Overview Table 65. QIAGEN Breast Cancer Liquid Biopsy Product Table 66. QIAGEN Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 67. QIAGEN Recent Development Table 68. Roche Diagnostics Company Details Table 69. Roche Diagnostics Business Overview Table 70. Roche Diagnostics Breast Cancer Liquid Biopsy Product Table 71. Roche Diagnostics Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 72. Roche Diagnostics Recent Development Table 73. Bio-Rad Laboratories Company Details Table 74. Bio-Rad Laboratories Business Overview Table 75. Bio-Rad Laboratories Breast Cancer Liquid Biopsy Product Table 76. Bio-Rad Laboratories Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 77. Bio-Rad Laboratories Recent Development Table 78. Myriad Genetics Company Details Table 79. Myriad Genetics Business Overview Table 80. Myriad Genetics Breast Cancer Liquid Biopsy Product Table 81. Myriad Genetics Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 82. Myriad Genetics Recent Development Table 83. Menarini Silicon Biosystems Company Details Table 84. Menarini Silicon Biosystems Business Overview Table 85. Menarini Silicon Biosystems Breast Cancer Liquid Biopsy Product Table 86. Menarini Silicon Biosystems Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 87. Menarini Silicon Biosystems Recent Development Table 88. Genomic Health Company Details Table 89. Genomic Health Business Overview Table 90. Genomic Health Breast Cancer Liquid Biopsy Product Table 91. Genomic Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 92. Genomic Health Recent Development Table 93. Thermo Fisher Scientific Company Details Table 94. Thermo Fisher Scientific Business Overview Table 95. Thermo Fisher Scientific Breast Cancer Liquid Biopsy Product Table 96. Thermo Fisher Scientific Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 97. Thermo Fisher Scientific Recent Development Table 98. Illumina Company Details Table 99. Illumina Business Overview Table 100. Illumina Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 101. Illumina Recent Development Table 102. Biocept Company Details Table 103. Biocept Business Overview Table 104. Biocept Breast Cancer Liquid Biopsy Product Table 105. Biocept Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 106. Biocept Recent Development Table 107. Trovagene Company Details Table 108. Trovagene Business Overview Table 109. Trovagene Breast Cancer Liquid Biopsy Product Table 110. Trovagene Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 111. Trovagene Recent Development Table 112. Guardant Health Company Details Table 113. Guardant Health Business Overview Table 114. Guardant Health Breast Cancer Liquid Biopsy Product Table 115. Guardant Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 116. Guardant Health Recent Development Table 117. RainDance Technologies Company Details Table 118. RainDance Technologies Business Overview Table 119. RainDance Technologies Breast Cancer Liquid Biopsy Product Table 120. RainDance Technologies Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 121. RainDance Technologies Recent Development Table 122. MDx Health Company Details Table 123. MDx Health Business Overview Table 124. MDx Health Breast Cancer Liquid Biopsy Product Table 125. MDx Health Revenue in Breast Cancer Liquid Biopsy Business (2016-2021) & (US$ Million) Table 126. MDx Health Recent Development Table 127. Research Programs/Design for This Report Table 128. Key Data Information from Secondary Sources Table 129. Key Data Information from Primary Sources List of Figures Figure 1. Global Breast Cancer Liquid Biopsy Market Share by Type: 2020 VS 2027 Figure 2. Circulating Tumor Cells (CTCs) Features Figure 3. Cell-Free DNA (CfDNA) Features Figure 4. Extracellular Vesicles (EVs) Features Figure 5. Other Circulating Biomarkers Features Figure 6. Global Breast Cancer Liquid Biopsy Market Share by Application: 2020 VS 2027 Figure 7. Hospitals Case Studies Figure 8. Diagnostic Centers Case Studies Figure 9. Laboratories Case Studies Figure 10. Breast Cancer Liquid Biopsy Report Years Considered Figure 11. Global Breast Cancer Liquid Biopsy Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Breast Cancer Liquid Biopsy Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Breast Cancer Liquid Biopsy Market Share by Regions: 2020 VS 2027 Figure 14. Global Breast Cancer Liquid Biopsy Market Share by Regions (2022-2027) Figure 15. Global Breast Cancer Liquid Biopsy Market Share by Players in 2020 Figure 16. Global Top Breast Cancer Liquid Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Liquid Biopsy as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Breast Cancer Liquid Biopsy Revenue in 2020 Figure 18. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2016-2021) Figure 19. Global Breast Cancer Liquid Biopsy Revenue Market Share by Type (2022-2027) Figure 20. North America Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Breast Cancer Liquid Biopsy Market Share by Type (2016-2027) Figure 22. North America Breast Cancer Liquid Biopsy Market Share by Application (2016-2027) Figure 23. North America Breast Cancer Liquid Biopsy Market Share by Country (2016-2027) Figure 24. United States Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Breast Cancer Liquid Biopsy Market Share by Type (2016-2027) Figure 28. Europe Breast Cancer Liquid Biopsy Market Share by Application (2016-2027) Figure 29. Europe Breast Cancer Liquid Biopsy Market Share by Country (2016-2027) Figure 30. Germany Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Type (2016-2027) Figure 38. Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Application (2016-2027) Figure 39. Asia-Pacific Breast Cancer Liquid Biopsy Market Share by Region (2016-2027) Figure 40. China Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Breast Cancer Liquid Biopsy Market Share by Type (2016-2027) Figure 48. Latin America Breast Cancer Liquid Biopsy Market Share by Application (2016-2027) Figure 49. Latin America Breast Cancer Liquid Biopsy Market Share by Country (2016-2027) Figure 50. Mexico Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Type (2016-2027) Figure 54. Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Application (2016-2027) Figure 55. Middle East & Africa Breast Cancer Liquid Biopsy Market Share by Country (2016-2027) Figure 56. Turkey Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Breast Cancer Liquid Biopsy Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. QIAGEN Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 60. Roche Diagnostics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 61. Bio-Rad Laboratories Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 62. Myriad Genetics Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 63. Menarini Silicon Biosystems Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 64. Genomic Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 65. Thermo Fisher Scientific Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 66. Illumina Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 67. Biocept Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 68. Trovagene Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 69. Guardant Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 70. RainDance Technologies Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 71. MDx Health Revenue Growth Rate in Breast Cancer Liquid Biopsy Business (2016-2021) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

QIAGEN Roche Diagnostics Bio-Rad Laboratories Myriad Genetics Menarini Silicon Biosystems Genomic Health Thermo Fisher Scientific Illumina Biocept Trovagene Guardant Health RainDance Technologies MDx Health